Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Sergio Vano-Galvan"'
Autor:
Wilma F. Bergfeld, Maria K. Hordinsky, S. Papanikou, Giselle Martins Pinto, Isabella Doche, Satoshi Itami, S. Malakar, K. Khobzei, Elise A. Olsen, Paradi Mirmirani, T. Silyuk, V. Chasapi, Rod Sinclair, Valerie D. Callender, Amy J. McMichael, Kenneth Washenik, Matthew Harries, R. O. Soares, Rodrigo Pirmez, N. Enechukwu, Lidia Rudnicka, Ulrike Blume-Peytavi, Won Soo Lee, Abraham Zlotogorski, Pascal Reygagne, David Saceda-Corralo, Yuliya Ovcharenko, Jerry Shapiro, A. Souissi, George Cotsarelis, Ramon Grimalt, O. Correia, Antonella Tosti, Douglas Canfield, Ncoza C. Dlova, Sergio Vano-Galvan, Annika Vogt, Rachita Dhurat, Andrew G. Messenger, Bianca Maria Piraccini, Janet L. Roberts
Publikováno v:
British Journal of Dermatology. 185:1221-1231
Background Frontal fibrosing alopecia (FFA) has become one of the most common causes of cicatricial alopecia worldwide. However, there is a lack of clear aetiology and robust clinical trial evidence for the efficacy and safety of agents currently use
Autor:
David Saceda-Corralo, Juan Jimenez-Cauhe, Sergio Vano-Galvan, Anna Waskiel-Burnat, Michela Starace, Kristen LoSicco, Rebekka Jerjen, Rodrigo Pirmez, Bianca Maria Piraccini, Rita Rodrigues-Barata, Pedro Jaén-Olasolo, Antonella Tosti, Janina Eliza Poa, Lu Yin, Rodney Sinclair, Lara Trindade de Carvalho, Lidia Rudnicka, Bevin Bhoyrul, Wei L. Koh, Colombina Vincenzi, José Luis Zamorano, Oscar M. Moreno-Arrones, Corina Isabel Salas-Callo, Jerry Shapiro, Jared Marc John, Ángela Hermosa-Gelbard
Publikováno v:
Journal of the American Academy of Dermatology. 84:1644-1651
Background The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects. Objective To describe the safety of LDOM for the treatment of hair loss in a large coho
Publikováno v:
Actas Dermo-Sifiliográficas, Vol 112, Iss 6, Pp 495-502 (2021)
Resumen: El microbioma incluye microorganismos como virus, bacterias y hongos. Se ha evidenciado que el cuero cabelludo tiene su propio microbioma dado por factores únicos como la humedad, la protección de luz ultravioleta y el pH; adicionalmente h
Autor:
C. Bernárdez, David Saceda-Corralo, Sergio Vano-Galvan, Ana Rita Rodrigues-Barata, Rocío Gil-Redondo, Oscar M. Moreno-Arrones, Ángela Hermosa-Gelbard
Publikováno v:
Journal of the American Academy of Dermatology. 86:181-183
Autor:
Matilde Iorizzo, Michela Starace, Sergio Vano-Galvan, Bianca Maria Piraccini, Pascal Reygagne, Lidia Rudnicka, Tatiana Silyuk, Rodney Sinclair, Antonella Tosti
Publikováno v:
Journal of the American Academy of Dermatology. 87(3)
Autor:
Florence Pouradier, Mariya Nevskaya, Kamila Padlewska, Michaela Havlíčková, Victor Desmond Mandel, Pascal Reygagne, Veronique Meuleman, Sergio Vano-Galvan, Delphine Kerob, Catherine Delva, Rose Khalil, Jean-François Michelet, Gilberto Adame Miranda
Publikováno v:
Dermatologic therapy. 34(6)
Introduction Androgenic alopecia (AGA) is a common and chronic condition. It may impact self-esteem, self-image and quality of life. Benefit, tolerability, cosmetic acceptance and patient satisfaction are key to ensuring good treatment outcome. Aim A
Autor:
Rachita Dhurat, Suraj Pai, John McCoy, Sergio Vano-Galvan, Sanober Burzin Daruwalla, Andy Goren, Jerry Shapiro, Rod Sinclair, Maja Kovacevic
Publikováno v:
Journal of cosmetic dermatologyREFERENCES. 21(1)
Background Minoxidil is a widely used over-the-counter topical treatment for hair loss. The response rate for topical minoxidil is relatively low. Minoxidil is a pro-drug, converted to its active form, minoxidil sulfate, by SULT1A1 enzymes located in
Autor:
Gerald Selda-Enriquez, Ana Melian-Olivera, David Saceda-Corralo, Laura Miguel-Gomez, Patricia Burgos-Blasco, Ana Suarez-Valle, Sergio Vano-Galvan
Publikováno v:
Journal of the American Academy of Dermatology. 87(1)
Autor:
Alba Gómez-Zubiaur, Oscar M. Moreno-Arrones, V Melgar‐Molero, María-Antonia Pastor-Nieto, Sergio Vano-Galvan, E Jiménez‐Blázquez
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 35
Autor:
Rodney Sinclair, Andy Goren, Sergio Vano-Galvan, Maja Kovacevic, Jerry Shapiro, Mohamad Goldust, Mirna Šitum, John McCoy
Publikováno v:
Journal of Cosmetic Dermatology. 19:2647-2649
Background: Topical minoxidil is the only US FDA- approved drug for the treatment of female pattern hair loss (FPHL). While the safety profile of topical minoxidil is excellent, the efficacy of minoxidil in hair growth is extremely low. A recent surv